ArticleBreast cancer research : BCR2011

Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.

Kirsi M Kuusisto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.